93 results on '"Farag, Sherif S."'
Search Results
2. A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease
3. Mgta-117, an Anti-CD117-Amanitin Antibody-Drug Conjugate, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics, and Pharmacodynamics Initial Findings from a Phase 1/2 Study
4. Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant
5. Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study
6. The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation
7. The in Vitro and In Vivo Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention
8. The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
9. Mgta-117, an Anti-CD117 Antibody-Drug Conjugated with Amanitin, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics and Pharmacodynamics Initial Findings from a Phase 1/2 Study
10. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis
11. Impacts of Total Body Irradiation in Allogeneic Umbilical Cord Blood Hematopoietic Stem Cell Transplant with Reduced Intensity Conditioning
12. Pre-Transplant M Protein Level Predicts Minimal Residual Disease Status after Autologous Stem Cell Transplantation in Multiple Myeloma
13. Impacts of Total Body Irradiation in Allogeneic Umbilical Cord Blood Hematopoietic Stem Cell Transplantation
14. Effect of family cohesion on symptom distress during hematopoietic stem cell transplantation
15. Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma
16. The Brain: Is it a Next Frontier to Better Understand the Regulation and Control of Hematopoiesis for Future Modulation and Treatment?
17. Targeting Homing to Enhance Engraftment Following Umbilical Cord Blood Stem Cell Transplantation
18. Effect of Family Cohesion On Symptom Distress During Hematopoietic Stem Cell Transplantation
19. Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease
20. Natural Killer Cell Activity and Killer Immunoglobulin-Like Receptors in Hematopoietic Stem Cell Transplantation
21. Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
22. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome
23. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups
24. Mitigating Damage Response with CD24 Fusion Protein for Prevention of Acute Graft-Versus-Host Disease
25. A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation.
26. Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to Reduce Acute Gvhd: Study Design on a Randomized Double Blind Placebo Controlled Phase III Clinical Trial (CATHY Study)
27. STEPS to Enhance Physical Activity after Hematopoietic Cell Transplantation for Multiple Myeloma
28. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation
29. Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
30. The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies
31. Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma
32. Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia
33. Higher Sirolimus Levels between Days 11-20 after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Increase the Risk of Hepatic Sinusuoidal Obstruction Syndrome (SOS) after Non-Busulfan Myeloablative Conditioning
34. High-Dose Thiotepa-Cyclophosphamide (TT/Cy) Results in Superior Outcomes Compared with Total Body Irradiation-Cyclophosphamide (TBI/Cy) in Patients with Acute Myeloid Leukemia (AML), Advanced Chronic Myeloid Leukemia (CML) and High-Grade Myelodysplasia (MDS) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
35. Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease
36. Assessment of ST2 for Risk of Death Following Graft-versus-Host Disease in the Pediatric and Adult Age Groups
37. Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors
38. High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation
39. P042 Impact of minor HLA allelic mismatches on outcomes of hematopoietic cell transplants
40. Higher CD34+ Cell Doses Reduce the Cost of Tandem Autologous Stem Cell Transplants for Relapsed or Refractory Germ Cell Tumors
41. Killer Cell Immunoglobulin-Like Receptor Ligand Mismatching: To Match or Mismatch?
42. Cord Blood Hematopoietic Cell Transplantation
43. Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia
44. The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma
45. Inhibition of PIM Kinases Mitigates DNA Repair Responses Following Anthracycline-Induced DNA Damage and Enhances the Anti-Tumor Activity of Doxorubicin Against Lymphoma Cells
46. Modelling the Sitagliptin Effect on Dipeptidyl Peptidase-4 Activity in Adults with Haematological Malignancies After Umbilical Cord Blood Haematopoietic Cell Transplantation
47. Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
48. In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological Malignancies
49. Differential stem- and progenitor-cell trafficking by prostaglandin E2
50. A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.